LVTX is a pharmaceutical company focused on biologicals for advanced prostate carcinoma. It recently secured a collaboration agreement with Merck to assist in the clinical trials and the financial burdens it imposes in a quid pro quo related to a share of product margins in the future. On the 15-minute chart, LVTX burst out of a long-standing consolidation...
Based on the graph only, not the company's performance. NOT A FINANCIAL ADVICE !
keep eyes on this! ZOM is going up again. this time will be new highs.
Symbol: NASDAQ:CTXR Indicators Lag RSI My Opinion: Bullish Comments: Just added to the watchlist on our site! Check out which other we've already added.